CTHZ — Cancer Treatment Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Cancer Treatment Holdings, fiscal year end - May 31st, USD millions except per share, conversion factor applied.

	1993 May 31st	1994 May 31st	1995 May 31st	1996 May 31st	1997 May 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10KSB
Standards:	—	—	—	—	—
Status:	Final	Final	Final	Final	Final
Revenue
Other Revenue
Total Revenue	8.49	7.52	11	11.9	17
Cost of Revenue
Gross Profit	7.74	7.25	0.309	4.64	6.3
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	8.51	7.45	10.6	11.2	17.5
Operating Profit	-0.018	0.065	0.423	0.667	-0.52
Gain / Loss on Sale of Assets
Other Net Non Operating Costs
Net Income Before Taxes	0.068	-0.45	0.85	0.662	-0.587
Provision for Income Taxes
Net Income After Taxes	0.208	-0.25	0.504	0.352	-0.332
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-0.095	-0.297	0.514	0.352	-0.332
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.095	-0.297	0.514	0.352	-0.332
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.08	-0.089	0.088	0.105	-0.1
Dividends per Share